Related Blogs

Tuesday, April 10, 2012

CorpWatch : Grey Market Drugs: Profiting from Poorly Managed U.S. Health Care

Modern pharmacy in Norway
Modern pharmacy in Norway (Photo credit: Wikipedia)
CorpWatch : Grey Market Drugs: Profiting from Poorly Managed U.S. Health Care:

 One company, Florida-based Atlantic Biologicals, recently emailed a Vermont pharmacy offering shortage drugs that "are AVAILABLE. Of course quantities are limited," it noted. Account executive Lisy Nicolas, who described herself as "***YOUR #1 GO-TO GIRL!" offered the pharmacies "service that will amaze you.” The email concluded, without a hint of irony, "HAVE A JOY FILLED DAY!!!!" (Emphasis in original.)

Some drugs fetch more than others. The San Antonio Express- News reported an "astonishing markup of 6,213 percent," for the lifesaving leukemia drug Cytarabine, from a grey-market price faxed to pharmacists.

An Institute for Safe Medication Practices survey released in late August 2011 reported that some 52 percent of respondents had bought drugs on the gray market in the last two years. Price hikes in this grey market are estimated to average 650 percent , according to Premier.

..
.ero
.
Enhanced by Zemanta